XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Balance Sheet Components (Tables)
9 Months Ended
Jul. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of accounts receivable

Accounts receivable, net of allowances

Accounts receivable, net of allowances, consist of the following:

 

 

July 1,
2023

 

 

October 1,
2022

 

(In thousands)

 

 

 

 

 

 

Accounts receivable

 

$

141,071

 

 

$

127,523

 

Allowance for credit losses

 

 

(2,655

)

 

 

(2,744

)

Allowance for sales incentives

 

 

(23,758

)

 

 

(23,573

)

Accounts receivable, net of allowances

 

$

114,658

 

 

$

101,206

 

 

Schedule of inventories

Inventories, net, consist of the following:

 

 

July 1,
2023

 

 

October 1,
2022

 

(In thousands)

 

 

 

 

 

 

Finished goods

 

$

240,117

 

 

$

406,657

 

Component parts

 

 

58,029

 

 

 

47,631

 

Inventories

 

$

298,146

 

 

$

454,288

 

Schedule of goodwill

The following table presents the changes in carrying amount of goodwill during the nine months ended July 1, 2023:

 

(In thousands)

 

 

 

Balance as of October 1, 2022

 

$

77,300

 

Effect of exchange rate changes on goodwill

 

 

4,479

 

Balance as of July 1, 2023

 

$

81,779

 

Schedule of finite-lived intangible assets, future amortization expense

The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity:

 

 

July 1, 2023

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Foreign Currency Translation

 

 

Net Carrying Value

 

 

Weighted-Average Remaining Life

 

(In thousands, except weighted-average remaining life)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade name

 

$

451

 

 

$

(94

)

 

$

2

 

 

$

359

 

 

 

4.75

 

Technology-based

 

 

31,480

 

 

 

(10,114

)

 

 

 

 

 

21,366

 

 

 

5.03

 

Total finite-lived intangible assets

 

 

31,931

 

 

 

(10,208

)

 

 

2

 

 

 

21,725

 

 

 

5.03

 

In-process research and development not subject to amortization

 

 

71,759

 

 

 

 

 

 

254

 

 

 

72,013

 

 

 

 

Total intangible assets

 

$

103,690

 

 

$

(10,208

)

 

$

256

 

 

$

93,738

 

 

 

 

 

 

The following table summarizes the estimated future amortization expense of the Company's intangible assets as of July 1, 2023:

 

Fiscal years ending

 

Future Amortization Expense

 

(In thousands)

 

 

 

Remainder of fiscal 2023

 

$

1,493

 

2024

 

 

5,969

 

2025

 

 

3,371

 

2026

 

 

3,042

 

2027

 

 

3,026

 

2028 and thereafter

 

 

4,824

 

Total future amortization expense

 

$

21,725

 

 

Schedule of accrued expenses

Accrued expenses consisted of the following:

 

 

July 1,
2023

 

 

October 1,
2022

 

(In thousands)

 

 

 

 

 

 

Accrued advertising and marketing

 

$

11,096

 

 

$

21,292

 

Accrued taxes

 

 

15,977

 

 

 

7,081

 

Accrued inventory and supply chain costs

 

 

37,531

 

 

 

51,011

 

Accrued product development

 

 

5,469

 

 

 

8,168

 

Accrued general and administrative expenses

 

 

18,740

 

 

 

21,634

 

Other accrued payables

 

 

3,098

 

 

 

104

 

Total accrued expenses

 

$

91,911

 

 

$

109,290

 

Changes in deferred balances and expected revenue recognition

The following table presents the changes in the Company’s deferred revenue:

 

 

July 1,
2023

 

 

July 2,
2022

 

(In thousands)

 

 

 

 

 

 

Deferred revenue, beginning of period

 

$

83,470

 

 

$

89,498

 

Recognition of revenue included in beginning of period deferred revenue

 

 

(21,049

)

 

 

(35,226

)

Revenue deferred, net of revenue recognized on contracts in the respective period

 

 

19,844

 

 

 

21,549

 

Deferred revenue, end of period

 

$

82,265

 

 

$

75,821

 

Remaining performance obligation

The Company expects the following recognition of deferred revenue as of July 1, 2023:

 

 

For the fiscal years ending

 

 

 

 

 

2023

 

 

2024

 

 

2025

 

 

2026

 

 

2027 and
Beyond

 

 

Total

 

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue expected to be recognized

 

$

5,592

 

 

$

18,985

 

 

$

16,685

 

 

$

14,285

 

 

$

26,718

 

 

$

82,265

 

Schedule of other current liabilities

Other current liabilities consist of the following:

 

 

July 1,
2023

 

 

October 1,
2022

 

(In thousands)

 

 

 

 

 

 

Reserve for returns

 

$

20,186

 

 

$

18,263

 

Short-term operating lease liabilities

 

 

5,089

 

 

 

10,532

 

Warranty liability

 

 

8,969

 

 

 

5,771

 

Other

 

 

4,356

 

 

 

5,083

 

Total other current liabilities

 

$

38,600

 

 

$

39,649

 

Schedule of product warranty liability

The following table presents the changes in the Company’s warranty liability:

 

 

July 1,
2023

 

 

July 2,
2022

 

(In thousands)

 

 

 

 

 

 

Warranty liability, beginning of period

 

$

5,771

 

 

$

5,604

 

Provision for warranties issued during the period

 

 

10,670

 

 

 

9,191

 

Settlements of warranty claims during the period

 

 

(7,472

)

 

 

(7,367

)

Warranty liability, end of period

 

$

8,969

 

 

$

7,428

 

 

 

Leases

On May 11, 2023, the Company amended its existing operating lease at the Lafayette City Center in Boston, Massachusetts. The effect of the modification was a partial reduction in the square footage of the lease and an extension of the lease term through July 2035. The modification resulted in the Company continuing to classify the lease as an operating lease, with an increase in right-of-use assets and lease liabilities totaling $31.6 million and $30.4 million, respectively.